Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2012
04/05/2012US20120083037 Non-Viral Transfection Agent
04/05/2012US20120083036 Polysaccharide transferase
04/05/2012US20120083033 Production of transgenic avians using improved retroviral vectors
04/05/2012US20120083032 Embryonic stem cell line and method for preparing the same
04/05/2012US20120083031 Method for tracing gram-negative bacteria inside animal model using stable and bioluminescence-based expression system therefor
04/05/2012US20120083024 Materials and Methods for Synthesis of a Flavor and Aroma Volatile in Plants
04/05/2012US20120083020 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms
04/05/2012US20120083016 Method for tracing gram-negative bacteria inside animal model using stable and bioluminescence-based expression system therefor
04/05/2012US20120083015 Antibodies against human tweak and uses thereof
04/05/2012US20120083013 Glucosyltransferase specific to position-4 of furofuran-type lignan, and polynucleotide encoding same
04/05/2012US20120083012 Expression System for Producing Multi-Enzyme Complexes and Uses Thereof
04/05/2012US20120082996 Il-21 variants
04/05/2012US20120082992 Equine parasite detection
04/05/2012US20120082987 Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof
04/05/2012US20120082986 Cell proliferation inhibitor
04/05/2012US20120082976 Method of screening for insulin secretion-potentiating agents
04/05/2012US20120082716 Cytotoxic agents
04/05/2012US20120082696 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/05/2012US20120082694 Recombinant Viral-Based Malaria Vaccines
04/05/2012US20120082693 Use of proteins and peptides encoded by the genome of a novel sars-associated coronavirus strain
04/05/2012US20120082684 Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gene
04/05/2012US20120082681 Anti-il12rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders
04/05/2012US20120082680 Antagonists of pcsk9
04/05/2012US20120082679 Antagonists of pcsk9
04/05/2012US20120082674 Enterococcus antigens
04/05/2012US20120082673 Human cytokine receptor
04/05/2012US20120082670 Cd33 binding agents
04/05/2012US20120082666 Antibody compositions and methods of use
04/05/2012US20120082664 Optimized antibodies that target cd19
04/05/2012US20120082663 Anti-cmet antagonists
04/05/2012US20120082662 Anti-cmet antagonists
04/05/2012US20120082660 Anti-tnf induced apoptosis (atia) diagnostic markers and therapies
04/05/2012US20120082648 Colonization factor (CF) antigens of enterotoxigenic escherichia coli in recombinant bacteria
04/05/2012US20120082644 Cytokines and neuroantigens for treatment of immune disorders
04/05/2012US20120082622 Macaca fascicularis CCL17
04/05/2012DE102011000036A1 Rekombinante plasmidhaltige Mehrkopie-CpG-Motive und deren Transformanten zur Anwendung als DNA-Adjuvans in Vogel-Impfstoffen Recombinant plasmid-containing multi-copy CpG motifs and their transformants for use as DNA adjuvant in vaccines Bird
04/05/2012CA2823678A1 Method for transformation of stramenopile
04/05/2012CA2821992A1 Engineered nucleic acids and methods of use thereof
04/05/2012CA2816150A1 Method for inducing mutations and/or epimutations in plants
04/05/2012CA2813466A1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
04/05/2012CA2813327A1 Genetic modifiers of cystic fibrosis
04/05/2012CA2813300A1 Recombinant polypeptides for membrane fusion and uses thereof
04/05/2012CA2813203A1 Anti-human ccr7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier
04/05/2012CA2813133A1 Anti-ceacam6 antibodies and uses thereof
04/05/2012CA2812957A1 Polypeptides that bind to human complement component c5
04/05/2012CA2812870A1 Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
04/05/2012CA2812854A1 A gene expression signature for the selection of high energy use efficient plants
04/05/2012CA2812756A1 Antibody against human prostaglandin e2 receptor ep4
04/05/2012CA2812745A1 Linker for unimolecular fret biosensor based on principle of fluorescence resonance energy transfer
04/05/2012CA2812650A1 Use of mirnas for the diagnosis, prophylaxis, treatment and follow-up of diseases involving macroautophagy abnormalities
04/05/2012CA2812430A1 Humanized anti-tnf-.alpha. antibody and antigen-binding fragment (fab) thereof and use of the same
04/05/2012CA2812306A1 Flavivirus domain iii vaccine
04/05/2012CA2811699A1 Fusion protein for secretory protein expression
04/05/2012CA2811608A1 In vivo reporter system
04/05/2012CA2811596A1 Use of an endogenous 2-micron yeast plasmid for gene over expression
04/05/2012CA2810825A1 Modulation of timp1 and timp2 expression
04/05/2012CA2808656A1 A method for making an enriched library
04/04/2012EP2436788A1 Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
04/04/2012EP2436775A1 Method for screening of regenerative medicine
04/04/2012EP2436771A1 Plants having enhanced yield-related traits and a method for making the same
04/04/2012EP2436770A1 Tomato plants having higher levels of resistance to Botrytis
04/04/2012EP2436769A1 Plant expression constructs and methods of utilizing same
04/04/2012EP2436768A1 Method for inducing mutations and/or epimutations in plants.
04/04/2012EP2436767A1 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
04/04/2012EP2436766A1 Means and methods for improved protein interaction screening
04/04/2012EP2436765A2 Recombinant factor X with no glycosylation and method for preparing the same
04/04/2012EP2436764A1 Method for highly sensitive detection of protein-protein interaction
04/04/2012EP2436762A1 Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure
04/04/2012EP2436761A1 Plants having improved growth characteristics and method for making the same
04/04/2012EP2436760A1 Plants having improved growth characteristics and method for making the same
04/04/2012EP2436756A2 Selective infarcted-tissue-targeting bacteria and use thereof
04/04/2012EP2436693A2 Synthetic genes encoding peptide fragments of natural myelin proteins for induction of oral tolerance, DNA fragment comprising these genes, means of obtaining these peptides in a microbial (bacterial) system and their medical application
04/04/2012EP2436690A1 Reversibly photoswitchable polypeptides
04/04/2012EP2436399A1 Polymeric nano-particles for siRNA delivery using charge interaction and covalent bonding
04/04/2012EP2436394A1 Peptide therapy
04/04/2012EP2436391A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
04/04/2012EP2436387A1 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
04/04/2012EP2435587A2 Advanced pathogen detection and screening
04/04/2012EP2435586A2 Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis
04/04/2012EP2435583A1 miR-31 IN DUCHENNE MUSCULAR DYSTROPHY THERAPY
04/04/2012EP2435575A2 Modified aav capsid polypeptides
04/04/2012EP2435574A1 A dna cassette, binary vector, and strain of a. tumefaciens and a method of producing cereal plant of increased productivity and/or root mass
04/04/2012EP2435573A2 Expression of recombinant proteins
04/04/2012EP2435572A2 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
04/04/2012EP2435571A2 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
04/04/2012EP2435570A1 Differentiation therapy for sarcomas
04/04/2012EP2435569A1 Method and device for producing and/or purifying polynucleotides and products obtainable thereof
04/04/2012EP2435568A1 A collection and methods for its use
04/04/2012EP2435567A1 Cdc45l peptides and vaccines including the same
04/04/2012EP2435566A2 Tumour-specific bacterial promoter elements
04/04/2012EP2435562A1 Compositions and methods for production of aglycosylated plasminogen
04/04/2012EP2435559A1 Simian adenovirus 41 and uses thereof
04/04/2012EP2435558A2 Generation of genetically corrected disease-free induced pluripotent stem cells
04/04/2012EP2435483A1 Photocatalytic hydrogen production in cyanobacteria
04/04/2012EP2435476A2 Avian derived antibodies
04/04/2012EP2435470A1 Muteins of the pyrroline-5-carboxylate reductase 1
04/04/2012EP2435179A1 Process for reactivating silica surfaces for the isolation of nucleic acids
04/04/2012EP2435078A1 Methods of treating inflammation
04/04/2012EP2435077A1 Stim2-mediated capacitive calcium entry
04/04/2012EP2435076A1 Anti-ck8 antibodies to be used for treating colorectal cancers and identifying metastatic and/or invasive phenotypes
1 ... 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 ... 4023